Arvinas, Inc. (ARVN)
7.30
-0.42
(-5.44%)
USD |
NASDAQ |
Oct 23, 16:00
7.28
-0.02
(-0.27%)
Pre-Market: 09:14
Arvinas Price to Book Value : 0.8479 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.8479 |
| October 22, 2026 | 0.8967 |
| October 21, 2026 | 0.8775 |
| October 20, 2026 | 0.8897 |
| October 19, 2026 | 0.8433 |
| October 16, 2026 | 0.8096 |
| October 15, 2026 | 0.8316 |
| October 14, 2026 | 0.7921 |
| October 13, 2026 | 0.7945 |
| October 12, 2026 | 0.8653 |
| October 09, 2026 | 0.8874 |
| October 08, 2026 | 0.8723 |
| October 07, 2026 | 0.8653 |
| October 06, 2026 | 0.8491 |
| October 05, 2026 | 0.8665 |
| October 02, 2026 | 0.8607 |
| October 01, 2026 | 0.863 |
| September 30, 2026 | 0.8984 |
| September 29, 2026 | 0.8711 |
| September 28, 2026 | 0.8723 |
| September 25, 2026 | 0.8816 |
| September 24, 2026 | 0.9048 |
| September 23, 2026 | 0.9095 |
| September 22, 2026 | 0.9884 |
| September 21, 2026 | 0.9641 |
| Date | Value |
|---|---|
| September 18, 2026 | 0.9629 |
| September 17, 2026 | 0.9652 |
| September 16, 2026 | 0.9478 |
| September 15, 2026 | 0.9594 |
| September 14, 2026 | 0.9757 |
| September 11, 2026 | 0.9815 |
| September 10, 2026 | 1.012 |
| September 09, 2026 | 1.018 |
| September 08, 2026 | 1.055 |
| September 04, 2026 | 1.091 |
| September 03, 2026 | 1.081 |
| September 02, 2026 | 1.114 |
| September 01, 2026 | 1.078 |
| August 31, 2026 | 1.069 |
| August 28, 2026 | 1.066 |
| August 27, 2026 | 1.073 |
| August 26, 2026 | 1.082 |
| August 25, 2026 | 1.115 |
| August 24, 2026 | 1.085 |
| August 21, 2026 | 1.088 |
| August 20, 2026 | 1.048 |
| August 19, 2026 | 1.124 |
| August 18, 2026 | 1.076 |
| August 17, 2026 | 1.069 |
| August 14, 2026 | 1.042 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 12.55 |
| CNBX Pharmaceuticals, Inc. | -- |
| Fulcrum Therapeutics, Inc. | 0.9035 |
| Definium Therapeutics, Inc. | 5.217 |
| LeonaBio, Inc. | 1.357 |
Price to Book Value Related Metrics
| PE Ratio | 45.51 |
| PS Ratio | 1.543 |
| Price | 7.30 |
| Earnings Yield | 2.20% |
| Market Cap | 476.69M |
| Normalized PE Ratio | 33.36 |